2,690 HCA Healthcare, Inc. $HCA Shares Acquired by Vise Technologies Inc.

Vise Technologies Inc. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 17.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,023 shares of the company’s stock after buying an additional 2,690 shares during the period. Vise Technologies Inc.’s holdings in HCA Healthcare were worth $7,691,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Sunbelt Securities Inc. boosted its position in HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after acquiring an additional 3,945 shares in the last quarter. Sei Investments Co. raised its position in shares of HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after acquiring an additional 100,764 shares in the last quarter. SEB Asset Management AB purchased a new stake in shares of HCA Healthcare during the 1st quarter worth $75,534,000. Darsana Capital Partners LP boosted its position in HCA Healthcare by 46.7% during the second quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after purchasing an additional 350,000 shares in the last quarter. Finally, Fund 1 Investments LLC bought a new position in HCA Healthcare in the second quarter worth about $975,000. 62.73% of the stock is currently owned by institutional investors.

Key Stories Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Wells Fargo raised its price target for HCA from $381 to $468 while maintaining an “equal weight” rating. The higher target reflects improved valuation support, although the rating signals limited expected upside at current levels. Wells Fargo HCA price-target update
• Positive Sentiment: HCA’s price target was also raised to $521 in a separate analyst update, while KeyCorp reportedly strengthened its earnings-per-share estimates. These revisions may support investor confidence in the company’s earnings outlook. HCA price target raised to $521 KeyCorp HCA EPS estimate update
• Neutral Sentiment: An HCA subsidiary is planning a senior-notes offering. The financing could provide capital for operations or investment, but it would also increase debt obligations; terms such as pricing and size will determine the ultimate impact. HCA subsidiary senior-notes offering HCA senior notes offering
• Neutral Sentiment: HCA released renderings for a planned $300 million hospital in Cape Coral, Florida, with tax support. The project points to long-term expansion but may require substantial capital before contributing meaningfully to earnings. HCA Cape Coral hospital project
• Negative Sentiment: A reported HCA data breach affected approximately 55,000 people, creating potential costs related to remediation, regulatory scrutiny and reputational damage. HCA data breach
• Negative Sentiment: Reports warn of payer pressure ahead of HCA’s 2027 outlook. Concerns over reimbursement rates and negotiations could weigh on margins and temper the benefit of stronger earnings estimates. HCA payer pressure outlook

Analysts Set New Price Targets

A number of brokerages have recently weighed in on HCA. Deutsche Bank Aktiengesellschaft set a $476.00 price target on HCA Healthcare in a research note on Monday, July 27th. Oppenheimer cut their price target on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. Mizuho set a $495.00 price target on shares of HCA Healthcare in a report on Wednesday, October 28th. Barclays boosted their price objective on shares of HCA Healthcare from $387.00 to $401.00 and gave the company an “equal weight” rating in a report on Thursday. Finally, Royal Bank Of Canada upped their target price on HCA Healthcare from $496.00 to $521.00 and gave the company an “outperform” rating in a research report on Friday. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $479.48.

HCA Healthcare Stock Down 1.1%

Shares of NYSE HCA opened at $467.89 on Tuesday. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52. The business’s 50 day moving average price is $438.21 and its 200 day moving average price is $444.84. The firm has a market cap of $101.30 billion, a P/E ratio of 15.50, a P/E/G ratio of 1.53 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.65 by $0.57. The company had revenue of $19.85 billion during the quarter, compared to analyst estimates of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. HCA Healthcare’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the firm posted $6.96 EPS. As a group, research analysts expect that HCA Healthcare, Inc. will post 30.15 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 29th. Investors of record on Tuesday, December 15th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is currently 10.34%.

HCA Healthcare Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.